181 related articles for article (PubMed ID: 33722692)
21. Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.
Yuan H; Guo H; Luan X; He M; Li F; Burnett J; Truchan N; Sun D
Mol Pharm; 2020 Jul; 17(7):2275-2286. PubMed ID: 32485107
[TBL] [Abstract][Full Text] [Related]
22. Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles.
Cheng B; Gao F; Maissy E; Xu P
Acta Biomater; 2019 Jan; 84():378-390. PubMed ID: 30528604
[TBL] [Abstract][Full Text] [Related]
23. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
24. Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy.
Son S; Shin S; Rao NV; Um W; Jeon J; Ko H; Deepagan VG; Kwon S; Lee JY; Park JH
Int J Biol Macromol; 2018 Apr; 110():406-415. PubMed ID: 29055700
[TBL] [Abstract][Full Text] [Related]
25. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
[TBL] [Abstract][Full Text] [Related]
26. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
27. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
28. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.
M-Rabet M; Cabaud O; Josselin E; Finetti P; Castellano R; Farina A; Agavnian-Couquiaud E; Saviane G; Collette Y; Viens P; Gonçalves A; Ginestier C; Charafe-Jauffret E; Birnbaum D; Olive D; Bertucci F; Lopez M
Ann Oncol; 2017 Apr; 28(4):769-776. PubMed ID: 27998973
[TBL] [Abstract][Full Text] [Related]
29. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J; Cescon DW; Rugo HS; Nowecki Z; Im SA; Yusof MM; Gallardo C; Lipatov O; Barrios CH; Holgado E; Iwata H; Masuda N; Otero MT; Gokmen E; Loi S; Guo Z; Zhao J; Aktan G; Karantza V; Schmid P;
Lancet; 2020 Dec; 396(10265):1817-1828. PubMed ID: 33278935
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
31. Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.
Parvani JG; Gujrati MD; Mack MA; Schiemann WP; Lu ZR
Cancer Res; 2015 Jun; 75(11):2316-2325. PubMed ID: 25858145
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
[TBL] [Abstract][Full Text] [Related]
33. Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells.
D'Ambrosio J; Fatatis A
Clin Exp Metastasis; 2009; 26(8):955-64. PubMed ID: 19768662
[TBL] [Abstract][Full Text] [Related]
34. 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.
Sethi P; Jyoti A; Swindell EP; Chan R; Langner UW; Feddock JM; Nagarajan R; O'Halloran TV; Upreti M
Nanomedicine; 2015 Nov; 11(8):2013-23. PubMed ID: 26282381
[TBL] [Abstract][Full Text] [Related]
35. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
[TBL] [Abstract][Full Text] [Related]
36. Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.
Guo C; Chen Y; Gao W; Chang A; Ye Y; Shen W; Luo Y; Yang S; Sun P; Xiang R; Li N
Theranostics; 2017; 7(3):775-788. PubMed ID: 28255366
[TBL] [Abstract][Full Text] [Related]
37. Metastatic breast cancer induces an osteoblast inflammatory response.
Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
[TBL] [Abstract][Full Text] [Related]
38. Involvement of hepatocyte growth factor in the development of bone metastasis of a mouse mammary cancer cell line, BALB/c-MC.
Ono K; Kamiya S; Akatsu T; Nakamura C; Li M; Amizuka N; Matsumoto K; Nakamura T; Kugai N; Wada S
Bone; 2006 Jul; 39(1):27-34. PubMed ID: 16459153
[TBL] [Abstract][Full Text] [Related]
39. Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer.
Shashni B; Nagasaki Y
Biomaterials; 2018 Sep; 178():48-62. PubMed ID: 29908344
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts.
Mercatali L; Spadazzi C; Miserocchi G; Liverani C; De Vita A; Bongiovanni A; Recine F; Amadori D; Ibrahim T
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27809291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]